VisualSonics unveils ‘revolutionary’ Vevo LAZR imaging system
VisualSonics, a high-resolution micro imaging systems manufacturer, has launched a new imaging system it claims will revolutionise cancer research.
Almac co-invests in cold storage capacity with US client
Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals, continuing the contract manufacturing organisation’s (CMO) busy expansion programme.
Lonza wins manufacturing deals with Enobia and Athera
Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.
Appointments at PharmStar, Cephalon, Covidien and Catalent – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PharmStar, Cephalon, Covidien and Catalent.
Inovio receives DNA vaccine delivery grant
Inovio has received a US grant to investigate delivering DNA vaccines to different parts of the body at the same time.
Appointments at Catalent, Cytel and Laureate Biopharmaceutical – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Cytel and Laureate Biopharmaceutical.
Therapeutic Ab deals: ChemPartner partners with Shenogen; Morphosys teams with Boehringer
Shanghai-based CRO, ChemPartner, a subsidiary of Chinese biotech outsourcing company, ShangPharma, has signed a research services agreement with China-based oncology specialists, Shenogen Pharma, to develop therapeutic antibodies for use in the treatment...
SAFC announce new POC manufacturing services
SAFC, the custom manufacturing wing of global healthcare giant Sigma Aldritch, has announced the launch of raw materials and custom services specifically developed for point-of-care (POC) diagnostics manufacture.
WSF report claims 'brighter decade lies ahead' for biotech sector
World Street Fundamentals (WSF), the financial research specialist, has released two industry reports highlighting the mixed fortunes of biotech firms Biodel and MannKind, but claims a “brighter decade” lies ahead for the biotech sector.
Carbon dioxide may be drug processing 'shortcut,' study
A new study suggests pressurised carbon dioxide can accelerate crystalisation during drug production, and potentially save manufacturers time and money.
New J&J recall insulin pump cartridges
US healthcare giant Johnson & Johnson (J&J) has recalled 384,000 of its insulin cartridges on concerns the products could cause serious health problems for diabetics.
Thermo rolls out predictive liver toxicity assay
Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.
Agilent buys Biocius Life Sciences for undisclosed amount
Agilent Technolgies, the Santa Clara, US-based scientific instrument manufacturer, has acquired instrument manufacturer and contract research organisation (CRO), Biocius Life Sciences, for an undisclosed amount.
Clondalkin to buy Catalent printed components unit
Clondalkin is to buy the printed components unit from Catalent as part of an ongoing acquisition strategy in the strong sector growth.
Clinipace buys regulatory affairs unit
Clinipace Worldwide has bought Regulus Pharmaceutical Consulting to add regulatory expertise to its eClinical contract research services business.
LG to build VLP vaccine site in S Korea using Novavax tech
LG Life Sciences is to build an influenza vaccine production facility in South Korea after licensing technology from Novavax.
Samsung inks multi-million dollar biosimilars deal with Quintiles
South Korea's Samsung Group has announced plans to form a 'strategic partnership' with US contract research organisation (CRO), Quintiles, as it gears up to enter the biopharma market.
Fujifilm acquires Merck BioManufacturing Network
Tokyo, Japan-based digital imaging specialist, Fujifilm, has agreed a deal to buy US drug giant Merck and Co's BioManufacturing Network, including two biotech manufacturing plants.
Viropro lands deal to acquire Alpha Biologics
US contract research and manufacturing services firm, Viropro, has signed a $21m (€15.3m) deal for the acquisition of Malaysia-based Alpha Biologics.
CIT to distribute hES based tox test in Europe
Non-clinical CRO CIT will distribute Stemina’s hES-based toxicity testing platform to pharmaceutical and cosmetics developers in Europe under an agreement announced late last week.
SPL responds to US FDA warning letter
US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.
RecipharmCobra gets EU patent for Xer-cise modification tech
RecipharmCobra Biologics has received an EU patent for a genetic modification tech that allows antibiotic resistance genes to be removed after insertion is complete.
Parexel sees Q2 revenue grow, but cuts 2011 outlook
US contract research organisation (CRO) Parexel has cut its 2011 guidance, citing slower backlog conversion from projects generated by “strategic partnerships” as basis for the revision.
Oxford Biomedica buys UK plant to cut reliance on CMO
Oxford Biomedica has bought RecipharmCobra Biologics’ manufacturing facility in Oxford, UK, to reduce its reliance on third-party production of its gene delivery technology.
Solid-state training to advance China beyond API infancy
Crystal Pharmatech is to provide solid-state characterisation training in China to advance local API and drug development beyond its “infancy phase”.
Abbott to cut 1,900 commercial & manufacturing jobs in US
Abbott Laboratories is to cut 1,900 US commercial and manufacturing jobs in response to healthcare reform and tough regulators.
Pfizer brings “best minds together” at New York Centre for Therapeutic Innovation
Pfizer’s Centres for Therapeutic Innovation (CTI) has teamed up with seven New York research hospitals to accelerate biomedical research into life-saving medicines, with a focus on biologics.
Genzyme to build new Belgium manufacturing plant
Genzyme will build a second manufacturing plant in Geel, Belgium to ensure it has the capacity to meet demand for its Pompe disease drugs Myozyme and Lumizyme.
Boehringer Ingelheim is to acquire a California, US manufacturing facility from Amgen to expand its contract biologics production capabilities.
CIT joins “ScreenTox” stem cell development project
French contract research organisation (CRO) CIT will work on in vitro toxicity testing for pharmaceutical and cosmetic ingredients as the newest member of the European “ScreenTox” network.
Telstar Puretech offers pharma water production solutions
Telstar Group and Puretech Process Systems are teaming up to meet the flood of pharma and biotech demand for water treatment technologies.
Merck targets biosimilars market with help from Parexel
Merck plans to cash in on the biogenerics industry after forming a partnership with Parexel to develop copies of biologic drugs within its Merck BioVentures division.
Entrega emerges from Enlight Biosciences
Enlight Biosciences, a Boston, US-based drug discovery and development technologies company, has formed the new company, Entrega, which focuses on oral drug delivery techniques.
Appointments at BioDelivery Sciences, SOCMA and Sanofi-aventis – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at BioDelivery Sciences, SOCMA and Sanofi-aventis.
Materials advances driving autoinjector market, report
Advances in materials technology are driving the autoinjection drug delivery device market according to new research.
PPD and Taijitu form MAb discovery JV
PPD and Taijitu Biologics have launched a new joint venture to help drugmakers develop the next generation of monoclonal antibody (MAb) drugs.
Drugmakers will make ‘aggressive changes’ to R&D this year, say researchers
Drug developers are “aggressively changing” research and development (R&D) methods in the pursuit of the next blockbuster, according to the Tufts Centre for the Study of Drug Development (Tufts CSDD).
Spectrum & Viropro to develop rituximab biosimilar
Spectrum Pharmaceuticals and Viropro are to develop a biosimilar version of rituximab, a monoclonal antibody cancer treatment sold by Roche and Biogen Idec.
Bayer injects €35m in biologics project expansion
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
ProJect Pharmaceutics opens Munich HQ and begins operations
ProJect Pharmaceutics has opened its Munich headquarters and laboratory facilities in Martinsreid, Germany, beginning business operations to transform proteins, peptides and small molecules into novel drugs.
Vical hails universal vaccine adjuvant in research review
Vical has published a review of Vaxfectin data showing the adjuvant boosts the immune response of DNA-based vaccines against cancer and a range of pathogens.
Takeda & Baxter aim to set up cell culture site in Japan
Takeda is collaborating with Baxter to establish a Vero cell-based influenza manufacturing facility in Japan and launch vaccines in the country.
Advinus brings services using Corning Epic to India
Advinus Therapeutics is to use Corning Epic label-free detection to provide clients in India and abroad with biologically relevant drug discovery data.
Lanxess opens Indian IER to meet demand for ultra pure water
Lanxess has opened an ion exchange resin production facility in India to cater for growing pharmaceutical manufacturing sector demand for ultrapure water.
Recognition of glass vial quality issues is supporting interest in West’s analytical capabilities and Crystal Zenith (CZ) products, new sizes of which are being developed, said a company VP.
Quintiles, London Genetics ink personalised medicine deal
Quintiles and London Genetics will offer pharmacogenetics solutions to the biopharma industry after collaborating to help advance personalised medicine.
Molecular Profiles expands into early-development
UK contract research organization (CRO) Molecular Profiles says speed to clinical is key demand driver for drug development sector.
Appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences.
EMD Millipore launches enhanced Mobius 3L CellReady Bioreactor
German pharmaceutical giant Merck's life science division, EMD Millipore, has launched its 'single-use' Mobius 3L CellReady Bioreactor, for use in the development and optimisation of cell culture processes.
Icon inks Proteome deal to bolster biomarker offering
Icon is adding protein and peptide profiling to its biomarker capabilities through a strategic alliance with Proteome Sciences.